Recursion Pharmaceuticals Summit Therapeutics: 2026 Insight
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Choosing the right guide to retirement planning is crucial for your future. Learn essential steps to secure a comfortable retirement.
22,974 articlesTwo biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Bitcoin trades near $58,000 after breaking below the $60,000 zone, triggering renewed concerns about the bitcoin pric...
GE Vernova surprised investors with strong momentum in the first half of 2026. This article breaks down what powered ...
Nvidia faces a temporary pullback as AI names retreat, but long‑term demand for data‑center GPUs and AI infrastructur...
Intel shares slipped about 6% in midday trading as HSBC boosted its price target 60% higher, while AMD and the broade...
Bitcoin eyes a pivotal breakout above 72K as bulls try to turn a fragile recovery into a sustained move. A breach of ...
As July 22 approaches, investors wonder if AMD stock could spark a move. This guide breaks down catalysts, risks, and...
Dogecoin's network activity surged to a multi-month high, fueling talk of a potential breakout. Analysts weigh how on...
SpaceX leaps past the $2 trillion mark as it eyes a spot in the Nasdaq-100, triggering intense debate about the susta...
Apple just pulled back after a strong run, leaving investors wondering if now is the time to buy. This article uses h...
Retail investors flock to a $50-priced ETF that looks like a safe cash substitute as rate expectations shift. Here’s ...
Bitcoin steadied near mid-$60,000s as oil prices jumped after Washington moved to tighten Iran-related waivers. A Jul...